Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management of Alzheimer’s disease

Faisal Imam; Sayantan Mukhopadhyay; Preeti Kothiyal; Samiyah Alshehri; Khalid Saad Alharbi; Muhammad Afzal; Muzaffar Iqbal; Mohammad Rashid Khan; Md. Khalid Anwer; Abdulrazaq Ahmed Hattab Alanazi; Ali Ghanem Alqahtani; Mohammed Abdullah Alhamamah

doi:10.1016/j.jsps.2024.102048

Citations

390

Views

Abstract not available for this publication.

Cite this Article (APA)

Faisal, I., Sayantan, M., Preeti, K., Samiyah, A., Khalid, S. A., Muhammad, A., Muzaffar, I., Mohammad, R. K., Md., K. A., Abdulrazaq, A. H. A., Ali, G. A., Mohammed, A. A. (2024). Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management of Alzheimer’s disease. Saudi Pharmaceutical Journal. https://doi.org/10.1016/j.jsps.2024.102048